Patents in genomics and human genetics

Robert Cook-Deegan, Christopher Heaney

Research output: Contribution to journalReview article

38 Citations (Scopus)

Abstract

Genomics and human genetics are scientifically fundamental and commercially valuable. These fields grew to prominence in an era of growth in government and nonprofit research funding, and of even greater growth of privately funded research and development in biotechnology and pharmaceuticals. Patents on DNA technologies are a central feature of this story, illustrating how patent law adapts-and sometimes fails to adapt-to emerging genomic technologies. In instrumentation and for therapeutic proteins, patents have largely played their traditional role of inducing investment in engineering and product development, including expensive postdiscovery clinical research to prove safety and efficacy. Patents on methods and DNA sequences relevant to clinical genetic testing show less evidence of benefits and more evidence of problems and impediments, largely attributable to university exclusive licensing practices. Whole-genome sequencing will confront uncertainty about infringing granted patents, but jurisprudence trends away from upholding the broadest and potentially most troublesome patent claims.

Original languageEnglish (US)
Pages (from-to)383-425
Number of pages43
JournalAnnual Review of Genomics and Human Genetics
Volume11
DOIs
StatePublished - Sep 22 2010
Externally publishedYes

Fingerprint

Patents
Medical Genetics
Genomics
Research
Technology
Genetic Testing
Jurisprudence
Licensure
Biotechnology
Growth
Uncertainty
Genome
Safety
DNA
Pharmaceutical Preparations
Proteins
Therapeutics

Keywords

  • DNA patents
  • gene patents
  • intellectual property
  • law
  • licensing
  • open source

ASJC Scopus subject areas

  • Genetics(clinical)
  • Genetics
  • Molecular Biology

Cite this

Patents in genomics and human genetics. / Cook-Deegan, Robert; Heaney, Christopher.

In: Annual Review of Genomics and Human Genetics, Vol. 11, 22.09.2010, p. 383-425.

Research output: Contribution to journalReview article

@article{065ba0b197f0436392b96daa4cda3346,
title = "Patents in genomics and human genetics",
abstract = "Genomics and human genetics are scientifically fundamental and commercially valuable. These fields grew to prominence in an era of growth in government and nonprofit research funding, and of even greater growth of privately funded research and development in biotechnology and pharmaceuticals. Patents on DNA technologies are a central feature of this story, illustrating how patent law adapts-and sometimes fails to adapt-to emerging genomic technologies. In instrumentation and for therapeutic proteins, patents have largely played their traditional role of inducing investment in engineering and product development, including expensive postdiscovery clinical research to prove safety and efficacy. Patents on methods and DNA sequences relevant to clinical genetic testing show less evidence of benefits and more evidence of problems and impediments, largely attributable to university exclusive licensing practices. Whole-genome sequencing will confront uncertainty about infringing granted patents, but jurisprudence trends away from upholding the broadest and potentially most troublesome patent claims.",
keywords = "DNA patents, gene patents, intellectual property, law, licensing, open source",
author = "Robert Cook-Deegan and Christopher Heaney",
year = "2010",
month = "9",
day = "22",
doi = "10.1146/annurev-genom-082509-141811",
language = "English (US)",
volume = "11",
pages = "383--425",
journal = "Annual Review of Genomics and Human Genetics",
issn = "1527-8204",
publisher = "Annual Reviews Inc.",

}

TY - JOUR

T1 - Patents in genomics and human genetics

AU - Cook-Deegan, Robert

AU - Heaney, Christopher

PY - 2010/9/22

Y1 - 2010/9/22

N2 - Genomics and human genetics are scientifically fundamental and commercially valuable. These fields grew to prominence in an era of growth in government and nonprofit research funding, and of even greater growth of privately funded research and development in biotechnology and pharmaceuticals. Patents on DNA technologies are a central feature of this story, illustrating how patent law adapts-and sometimes fails to adapt-to emerging genomic technologies. In instrumentation and for therapeutic proteins, patents have largely played their traditional role of inducing investment in engineering and product development, including expensive postdiscovery clinical research to prove safety and efficacy. Patents on methods and DNA sequences relevant to clinical genetic testing show less evidence of benefits and more evidence of problems and impediments, largely attributable to university exclusive licensing practices. Whole-genome sequencing will confront uncertainty about infringing granted patents, but jurisprudence trends away from upholding the broadest and potentially most troublesome patent claims.

AB - Genomics and human genetics are scientifically fundamental and commercially valuable. These fields grew to prominence in an era of growth in government and nonprofit research funding, and of even greater growth of privately funded research and development in biotechnology and pharmaceuticals. Patents on DNA technologies are a central feature of this story, illustrating how patent law adapts-and sometimes fails to adapt-to emerging genomic technologies. In instrumentation and for therapeutic proteins, patents have largely played their traditional role of inducing investment in engineering and product development, including expensive postdiscovery clinical research to prove safety and efficacy. Patents on methods and DNA sequences relevant to clinical genetic testing show less evidence of benefits and more evidence of problems and impediments, largely attributable to university exclusive licensing practices. Whole-genome sequencing will confront uncertainty about infringing granted patents, but jurisprudence trends away from upholding the broadest and potentially most troublesome patent claims.

KW - DNA patents

KW - gene patents

KW - intellectual property

KW - law

KW - licensing

KW - open source

UR - http://www.scopus.com/inward/record.url?scp=77957968264&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77957968264&partnerID=8YFLogxK

U2 - 10.1146/annurev-genom-082509-141811

DO - 10.1146/annurev-genom-082509-141811

M3 - Review article

VL - 11

SP - 383

EP - 425

JO - Annual Review of Genomics and Human Genetics

JF - Annual Review of Genomics and Human Genetics

SN - 1527-8204

ER -